Oncotarget

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2019; 10:1344.

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR

Jordan Madic, Cécile Jovelet, Julien Lopez, Barbara André, Jean Fatien, Isabelle Miran, Aurélie Honoré, Laura Mezquita, Benjamin Besse, Ludovic Lacroix and Magali Droniou _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:37393-37406. https://doi.org/10.18632/oncotarget.26446

Metrics: PDF 2965 views  |   HTML 2288 views  |   ?  


Abstract

Jordan Madic1,*, Cécile Jovelet2,*, Julien Lopez1, Barbara André1, Jean Fatien3, Isabelle Miran2, Aurélie Honoré2, Laura Mezquita5, Benjamin Besse5, Ludovic Lacroix2,4,* and Magali Droniou1,*

1Stilla Technologies, 1 Mail du Professeur Georges Mathé, Villejuif, France

2Plateforme de Génomique, Module de Biopathologie Moléculaire et Centre de Ressources Biologiques, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France

3Ecole Polytechnique, Route de Saclay, Palaiseau, France

4Département de Biologie et Pathologie Médicales, Institut Gustave Roussy, Villejuif, France

5Département d’Oncologie Médicale, Gustave Roussy, Villejuif, France

*These authors have contributed equally to this work

Correspondence to:

Magali Droniou, email: magali.droniou@stilla.fr

Keywords: EGFR; multiplexing; monitoring; NSCLC; digital PCR

Received: June 21, 2018    Accepted: November 26, 2018    Published: December 21, 2018

ABSTRACT

Background: Detection of EGFR sensitizing and p.T790M and p.C797S resistance mutations is particularly important for non-small cell lung cancer (NSCLC) patient therapy management. Non-invasive blood-based monitoring of these mutations may pave the way to a fine-tuned personalized treatment. Digital PCR has emerged as an extremely sensitive method to detect rare mutations, however its major limitation is the number of hotspots that can be simultaneously differentiated.

Methods: We developed a 6-color digital PCR assay for the detection and quantification of 19 most prevalent EGFR sensitizing and resistance mutations and evaluated this assay on 82 tumor and plasma samples from NSLC patients.

Results: Limits of detection (LOD) for the 6-color digital PCR assay were assessed on serial dilutions of DNA standards. We found that the 6-color assay enabled detection of mutant fractions as low as 1 mutant in 1025 wild-type molecules, depending on the mutation targeted, when assayed in a background of 10 000 wild-type DNA copies. EGFR mutant allelic fraction was also measured on tumor and plasma samples by 6-color digital PCR, and displayed a highly significant correlation with next generation sequencing and 3-color digital PCR. Lastly, the 6-color digital PCR assay was performed on several longitudinal plasma samples from four patients and revealed levels of sensitizing and resistance EGFR mutations that reflected well the course of the disease.

Conclusion: This 6-color Crystal digital PCR assay could represent a robust solution using digital PCR for the monitoring of EGFR mutations.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26446